Literature DB >> 27005692

Extrahepatic manifestations of hepatitis E virus.

Nassim Kamar1,2,3, Olivier Marion1, Florence Abravanel2,3,4, Jacques Izopet2,3,4, Harry R Dalton5.   

Abstract

Hepatitis E virus can cause acute, fulminant and chronic hepatitis and has been associated with a range of extrahepatic manifestations. Guillain-Barré syndrome, neuralgic amyotrophy and encephalitis are the main neurological manifestations associated with acute and chronic hepatitis E virus infection. Renal injuries have been also reported, including membranoproliferative glomerulonephritis with or without cryoglobulinemia and membranous glomerulonephritis. Acute pancreatitis, haematological disorders and other autoimmune extrahepatic manifestations of hepatitis E virus, such as myocarditis and thyroiditis, have been also reported. In this comprehensive article, we review all published reports describing hepatitis E virus-associated extrahepatic manifestations.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Anaemia; Guillain-Barré syndrome; hepatitis E virus; kidney disease; neuralgic amyotrophy; pancreatitis; thrombocytopenia

Mesh:

Year:  2016        PMID: 27005692     DOI: 10.1111/liv.13037

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  41 in total

Review 1.  Acute and Persistent Hepatitis E Virus Genotype 3 and 4 Infection: Clinical Features, Pathogenesis, and Treatment.

Authors:  Nassim Kamar; Sven Pischke
Journal:  Cold Spring Harb Perspect Med       Date:  2019-07-01       Impact factor: 6.915

Review 2.  Natural History, Clinical Manifestations, and Pathogenesis of Hepatitis E Virus Genotype 1 and 2 Infections.

Authors:  Rakesh Aggarwal; Amit Goel
Journal:  Cold Spring Harb Perspect Med       Date:  2019-07-01       Impact factor: 6.915

3.  Vectorial Release of Hepatitis E Virus in Polarized Human Hepatocytes.

Authors:  Nicolas Capelli; Olivier Marion; Martine Dubois; Sophie Allart; Justine Bertrand-Michel; Sébastien Lhomme; Florence Abravanel; Jacques Izopet; Sabine Chapuy-Regaud
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

4.  Prevalence, morbidity, and therapy of hepatitis E virus infection in pediatric renal allograft recipients.

Authors:  Stephanie E Cordts; Lukas Schneble; Paul Schnitzler; Jürgen J Wenzel; Tobias Vinke; Susanne Rieger; Alexander Fichtner; Burkhard Tönshoff; Britta Höcker
Journal:  Pediatr Nephrol       Date:  2018-03-02       Impact factor: 3.714

5.  Production of a Hepatitis E Vaccine Candidate Using the Pichia pastoris Expression System.

Authors:  Jyoti Gupta; Amit Kumar; Milan Surjit
Journal:  Methods Mol Biol       Date:  2022

6.  Parsonage-Turner syndrome due to autochthonous acute genotype 3f hepatitis E virus infection in a nonimmunocompromised 55-year-old patient.

Authors:  A Velay; W Kack-Kack; F Abravanel; S Lhomme; P Leyendecker; L Kremer; P Chamouard; J Izopet; S Fafi-Kremer; H Barth
Journal:  J Neurovirol       Date:  2017-04-24       Impact factor: 2.643

7.  Probable transmission of hepatitis E virus (HEV) via transfusion in the United States.

Authors:  John R Ticehurst; Nora Pisanic; Michael S Forman; Carly Ordak; Christopher D Heaney; Edgar Ong; Jeffrey M Linnen; Paul M Ness; Nan Guo; Hua Shan; Kenrad E Nelson
Journal:  Transfusion       Date:  2019-01-31       Impact factor: 3.157

Review 8.  Hepatitis E: What We Think We Know.

Authors:  Aradhna Seth; Kenneth E Sherman
Journal:  Clin Liver Dis (Hoboken)       Date:  2020-03-02

Review 9.  Neuralgic amyotrophy triggered by hepatitis E virus: a particular phenotype.

Authors:  Quentin Scanvion; Thierry Perez; François Cassim; Olivier Outteryck; Aurélia Lanteri; Pierre-Yves Hatron; Marc Lambert; Sandrine Morell-Dubois
Journal:  J Neurol       Date:  2017-02-28       Impact factor: 6.682

Review 10.  Mechanism of Cross-Species Transmission, Adaptive Evolution and Pathogenesis of Hepatitis E Virus.

Authors:  Putu Prathiwi Primadharsini; Shigeo Nagashima; Hiroaki Okamoto
Journal:  Viruses       Date:  2021-05-14       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.